.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Dow
Cantor Fitzgerald
Chubb
Colorcon
Boehringer Ingelheim
Baxter
Express Scripts
Daiichi Sankyo
Teva

Generated: July 21, 2017

DrugPatentWatch Database Preview

Gadoterate meglumine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for gadoterate meglumine and what is the scope of gadoterate meglumine patent protection?

Gadoterate meglumine
is the generic ingredient in one branded drug marketed by Guerbet and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for Generic Name: gadoterate meglumine

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list37
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:gadoterate meglumine at DailyMed

Pharmacology for Ingredient: gadoterate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Guerbet
DOTAREM
gadoterate meglumine
SOLUTION;INTRAVENOUS204781-003Mar 20, 2013RXYesYes► Subscribe► Subscribe
Guerbet
DOTAREM
gadoterate meglumine
SOLUTION;INTRAVENOUS204781-002Mar 20, 2013RXYesYes► Subscribe► Subscribe
Guerbet
DOTAREM
gadoterate meglumine
SOLUTION;INTRAVENOUS204781-004Mar 20, 2013RXYesYes► Subscribe► Subscribe
Guerbet
DOTAREM
gadoterate meglumine
SOLUTION;INTRAVENOUS204781-001Mar 20, 2013RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
US Department of Justice
Johnson and Johnson
QuintilesIMS
Boehringer Ingelheim
Colorcon
Merck
Deloitte
Healthtrust
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot